Clinical trial Recruiting at 1 site Observational Ages 18 and up

Investigating fasting insulin and insulin resistance across different demographics

Official title: Measuring Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Run by Lilli Health · NCT05950282 · Data updated 2026-11-12

This study looks at how fasting insulin levels and insulin resistance vary among different groups of people based on age, sex, race, weight, and conditions like PCOS to better understand metabolic health.

More Obesity trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorLilli Health
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedFebruary 1, 2024
Main results expectedOctober 2027
Study endsDecember 2027
Registry record updatedMay 1, 2026
Trial IDNCT05950282 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older, regardless of sex, from diverse racial and ethnic backgrounds, with varying BMI values, including those with and without a PCOS diagnosis.

Probably not a fit

Patients under 18 years old or those with other endocrine disorders affecting insulin levels may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the relationship between fasting insulin levels and the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) in relation to various demographic factors such as age, sex, race/ethnicity, BMI, and the diagnosis of polycystic ovary syndrome (PCOS). By analyzing these variables, the study seeks to uncover potential variations in insulin levels that could provide insights into metabolic health and the risk of insulin-related conditions. The findings may help identify how different factors contribute to insulin dysregulation and metabolic disorders.

Why it matters

Potential benefit: If successful, this study could enhance understanding of metabolic health and lead to better management strategies for conditions like insulin resistance and PCOS.

How similar studies have gone: While there have been studies examining insulin resistance and demographic factors, this specific approach focusing on the interplay of multiple variables in a diverse population is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria Age: Participants aged 18+ years Sex: Both males and females Race/Ethnicity: Participants from diverse racial and ethnic backgrounds BMI: Participants across a range of body mass index (BMI) values PCOS Diagnosis: Participants with and without a confirmed diagnosis of PCOS based on established diagnostic criteria

Participants must have completed metabolic testing within one month prior to enrollment, including:

* Fasting insulin
* Hemoglobin A1c (A1c)
* Complete lipid panel
* Triglycerides Laboratory testing must be completed through a healthcare provider, an independent laboratory, or by using an Insara Insulin Testing Kit Laboratory values must be obtained following a minimum 8-hour fast Participants must have complete laboratory data for all required measures

Exclusion Criteria Age: Participants below 18 years Sex: None. Both males and females are included Race/Ethnicity: None. Participants from all racial and ethnic backgrounds are included Endocrine Disorders: Participants with other endocrine disorders affecting insulin levels (e.g., insulin-secreting tumors) Significant recent weight change: Loss of more than 5% of body weight within the previous month Pregnancy or breastfeeding Acute illness or infection within the past 2 weeks Use of medications known to significantly affect insulin or glucose metabolism will be recorded and accounted for in analysis

Where it's running

  • Lilli Health
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.